DSM Firmenich partners with ExoLab Italia to bring plant-derived exosome technology to the skin care market

DSM Firmenich has partnered with ExoLab Italia to bring innovative plant-derived exosome technology to the global skin care market.

Plant-derived exosomes offer multiple benefits for personal care and beauty products and ultimately skin health. They're packed with a powerful blend of antioxidants, vitamins, proteins, lipids, and messenger molecules that work together to enhance skin health and fight signs of aging.

Gabriele Campi, CEO of ExoLab Italia said: "By focusing on plant-derived exosomes, ExoLab Italia offers unique scientific capabilities in cellular health and skin recovery, combined with DSM Firmenich’s renowned expertise in skin biology, claim substantiation and active ingredients, offering tremendous potential to raise the standard of natural, effective skin care to unprecedented heights."

Emmanuel Butstraen, President of DSM Firmenich Fragrance and Beauty said:"I am delighted to welcome ExoLab Italia as a new partner of DSM Firmenich. By partnering with this pioneer in exosome therapeutics, we reaffirm our commitment to science as a core element of our innovation and product differentiation."

Parand Salmassinia, President, DSM Firmenich Personal Care said:"We are delighted to embark on this journey with ExoLab Italia. We firmly believe that, together, we have the power to revolutionize the skin care market. This partnership is fully in line with our commitment to provide customers with the highest quality products and meet the growing demand for natural, effective and sustainable ingredients in the skin care market."